Xantos Labs Review: Low-Cost Hedge Fund Style Investing

Xantos Laps Review Featured
Some links on our website are sponsored, and we may earn money when you make a purchase or sign-up after clicking. Learn more about how we make money and read our review methodology.

Xantos Labs is an actively-managed investment platform with the goal of outperforming the S&P 500. 

Many actively-managed mutual funds have 200+ holdings, and while this provides diversification, it also means that the fund’s returns are strongly correlated with the S&P 500.

Xantos Labs takes a more aggressive approach, limiting its holdings to around 25 at any given time. In addition, Xantos allows you to customize your investing approach based on your risk tolerance. 

In this Xantos Labs review, we’ll take an in-depth look at the platform and help you decide if Xantos Labs is right for you.


Xantos Labs offers equity investors the type of strategies found in the institutional and ultra-high-net-worth space. Through 2022, Xantos has underperformed the S&P 500 by .8% since inception.

  • Available in 150+ countries and multiple currencies.
  • Low minimum investment of $500.
  • No performance fees
  • Limited track record.
  • Low total assets under management.
  • Taxable accounts only.
  • Limited to equities and bonds (no crypto).

Overview of the Xantos Labs Investing Methodology

Xantos Labs was founded in 2016 by Chuk Orakwue, Olamide Harrison and Oladipo Tokunboh. It operated as a private fund for three years, and opened to public investment in 2019. According to a recent SEC filing, the firm’s assets under management totaled just over $2 million.

Xantos Labs Key Facts

  • Assets: U.S.-based equities and ETFs.
  • Account minimum: $500.
  • SIPC insurance: Up to $500,000.
  • Account Fees: Greater of 2% AUM or $5/month
  • Assets under management: $2.2 million as of 12/31/21.

Xantos Labs Investment Strategy

While the goal of Xantos Labs’ Core Fund (which is currently the firm’s main fund) is to beat the market, how the company aims to accomplish that can change over time. Their guiding principle is to produce risk-adjusted returns over and above benchmarks like the S&P 500.

In other words, they aim to produce a greater return than you would get from the S&P 500 (and to do so with less risk).

One way they aim to achieve this is by offering significant downside protection. 

When you sign up for Xantos Labs, you’re asked to choose your risk tolerance. Your chosen risk tolerance will determine the allocations in your portfolio. 

Go with a conservative allocation and Xantos Labs will allocate your holdings towards sectors like consumer and healthcare, which have traditionally performed better in a down market. More aggressive? Your allocation would have more growth stocks, which offers more potential but carries more risk. 

Xantos Labs also adds bond ETFs (with a maximum proportional allocation of 15%) to portfolios of the most conservative investors. 

Xantos Labs currently has one fund (their Core Fund), which is customized based on your risk tolerance. In the near future, the company is planning to launch two additional funds, including a dividend-focused equity fund and a growth-focused fund. 

Xantos Labs vs. Titan

Xantos LabsTitan Invest
Fees:Greater of 2% AUM or $5/month$5 per month for accounts under $10,000 and 1% for accounts above $10,000.
Performance fee:0%0%
Assets under management:$2.2 million.$750 million.
Types of assets:Equities.Equities and crypto.
Portfolios available:14
Hedging strategy:Bond ETFs.Uses ProShares Short S&P 500 ETF as a hedge. Amount of hedge is based on chosen level of risk tolerance.

Titan was one of the first consumer-facing investment platforms promising to make hedge fund management strategies available to everyday investors.

Since launching in February 2018, Titan has received over $73 million in funding, including $58 million from A16Z in 2021, which placed its total value at $450 million. Due to its success, it’s no surprise that we’re seeing more funds targeting the same market — one of which is Xantos Labs.

Looking at its total assets under management, Xantos Labs is in the very beginning stages. They also don’t have many of the extra features offered by Titan, such as retirement accounts and multiple portfolio options (although those are in the company’s short-term plans). 

As for the investing strategy itself, as discussed in our Titan Invest review, Titan offers four different portfolios:

  1. Titan Flagship. A large-cap, U.S.-focused growth fund.
  2. Titan Opportunities. A small-cap, U.S.-focused growth fund.
  3. Titan Offshore. An international growth fund focused on medium to large companies outside of the U.S.
  4. Titan Crypto. An actively-managed crypto-only fund.

Similar to Xantos Labs, the goal of each strategy is to outperform its relative benchmark.

A difference in investment strategies between the two companies is their hedging strategy. For conservative investors, Titan will allocate more of your holdings to the ProShares Short S&P 500 ETF,  which rises when the market falls. By comparison, Xantos uses a more conservative stock allocation, as well as bond ETFs as an inflation hedge. 

Final Thoughts on Xantos Labs

With just $2.2 million under management, Xantos Labs is new to this space. Investing with Xantos Labs requires being comfortable with where they’re at as a company.

While I like that more companies are aiming to provide better products to everyday investors, trying to outperform the market always comes with added risk (as discussed in our guide to investing in individual stocks). 

So if you’re investing for retirement, it’s important that you’re not relying on outperformance — which is very difficult to achieve, no matter how advanced the strategy. 

R.J. Weiss
R.J. Weiss, founder of The Ways To Wealth, has been a CERTIFIED FINANCIAL PLANNER™ since 2010. Holding a B.A. in finance and having completed the CFP® certification curriculum at The American College, R.J. combines formal education with a deep commitment to providing unbiased financial insights. Recognized as a trusted authority in the financial realm, his expertise is highlighted in major publications like Business Insider, New York Times, and Forbes.

    Leave a reply

    Your email address will not be published. Required fields are marked *

    Read our comment policy.